Premium Reports
Contact KLAS
 Download Report    Zoom in charts

Preferences

   Bookmark

Related Series

 No Related Series

Related Segments

 End chart zoom
Drug Diversion Monitoring 2021 Drug Diversion Monitoring 2021
* A page refresh may be necessary to see the updated image

Drug Diversion Monitoring 2021
Energy High for Next-Generation Solutions (A Decision Insights Report)

author - Jackson Tate
Author
Jackson Tate
author - Jennifer Hickenlooper
Author
Jennifer Hickenlooper
 
January 4, 2022 | Read Time: 9  minutes

Current Time Inside Cache Tag Helper: 9/29/2022 3:13:32 AM and Model.reportId = 2020

In the last 12 months, KLAS has interviewed 41 healthcare organizations that have recently purchased a drug diversion monitoring solution or are in the process of doing so. This represents a sharp increase in market activity. Several factors are fueling the growth, including greater awareness of the opioid crisis as well as a greater need during the COVID-19 pandemic for visibility and automation when it comes to managing medication inventories. Additionally, organizations are considering several newer technology options purported to offer more intuitive workflows and more complete investigational tools. This report examines recent and upcoming drug diversion monitoring purchase decisions to determine which vendors are generating the highest interest.

to see the full dataset.

if you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.
Current Time Inside Cache Tag Helper: 9/29/2022 3:13:32 AM and Model.reportId = 2020

Findings in this report come from KLAS’ Decision Insights data, which monitors which vendors are being replaced, considered, and purchased and what factors drive these decisions. A future report planned for early 2022 will examine the satisfaction of current customers in areas such as integration, functionality, and ease of use. Early ratings from that research can be found here.

Key Findings:

  1. Kit Check Leads Considerations and Selections Due to Advanced Technology
  2. Most Legacy Medacist Customers Leaving for Other Vendors
  3. Very Large Organizations Most Commonly Choose BD and Kit Check
  4. HelioMetrics and Invistics See Few Selections
  5. Vendors at a Glance
author - Elizabeth Pew
Writer
Elizabeth Pew
author - Jessica Bonnett
Designer
Jessica Bonnett
author - Mary Bentley
Project Manager
Mary Bentley
 Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2022 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

Related Segments